The Journal of the Association of Physicians of India
-
J Assoc Physicians India · Oct 2003
Case ReportsReversible leg ulcer due to hydroxyurea in a case of chronic myeloid leukemia.
The cutaneous side effects of hydroxyurea are lesser known complication of long term hydroxyurea therapy in myeloproliferative disorders. We report a non-diabetic patient, who developed hydroxyurea dermopathy (leg ulcers) during long-term treatment with hydroxyurea for chronic myeloid leukemia (CML). The time course of the development of ulcers and its healing suggests that these resulted from the direct toxicity of hydroxyurea. We aim to increase clinical awareness of this problem.
-
Several studies have been published in western literature on incidence, prevalence, clinical course, outcome and mortality in patients with acute respiratory distress syndrome (ARDS). There are very few studies on the pattern of ARDS seen in Indian population. There are anecdotal reports of ARDS associated with different tropical diseases and the exact association of these life-threatening disorders with ARDS is not clearly described in the Indian literature. The study was carried out to identify the clinical pattern of Indian patients who died of ARDS. ⋯ Primary pulmonary infection was associated with ARDS is one-third of patients. Multiorgan failure was seen in 18% of patients who died from ARDS. Severe sepsis was identified as a significant risk factor for ARDS.
-
Brainstem death and brain death although practically same with regards to the concept of organ donation, remain technically different. Brain death mandates irreversible cessation of all the functions of the entire brain and brainstem while brainstem death signifies irreversible damage to the brainstem. As per the Indian law, brainstem death is the legal requirement and not brain death.
-
J Assoc Physicians India · Aug 2003
ReviewGastrointestinal stromal tumour--a paradigm shift in management of solid tumours.
Gastrointestinal stromal tumour (GIST) till recently were non-responsive to all chemotherapy agents. With the advent of c-kit, diagnosis of GIST has become more specific. STI-571, a tyrosine kinase, has become one of the first targeted therapeutic agent tobe active in solid tumour. At present it is the only agent with substantial activity in GIST.